Piscataway (New Jersey) [US], February 11: Kashiv BioSciences, LLC ("Kashiv") a vertically integrated biopharmaceutical company, today announced that it has entered into an exclusive licensing and supply agreement with Intas Pharmaceuticals Ltd ("Intas"), a leading multinational pharmaceutical company. The complex peptide product will be commercialized by Intas in India and its subsidiary, Accord Healthcare Ltd ("Accord"), in Europe and the UK.
